Literature DB >> 3011271

Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.

A Leder, P K Pattengale, A Kuo, T A Stewart, P Leder.   

Abstract

We have constructed a transgenic mouse strain in which a mammary tumor virus LTR/c-myc fusion gene is anomalously expressed in a wide variety of tissues. The deregulated c-myc transgene, now glucocorticoid inducible, contributes to an increased incidence of a variety of tumors, including those of testicular, breast, lymphocytic (B cell and T cell), and mast cell origin. The deregulated gene does not, however, otherwise disturb cell proliferation, nor does it interfere with normal development in these animals. Moreover, since not all tissues that express the transgene develop neoplasms, these results begin to define the transforming spectrum of the c-myc oncogene. They also extend to several organ systems the notion that elements in addition to an activated c-myc gene are required to induce malignancy in the living organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011271     DOI: 10.1016/0092-8674(86)90280-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  124 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  Intellectual property law: a primer for scientists.

Authors:  William M Brown
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.695

Review 3.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

4.  Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

Authors:  D Murphy; A Bishop; G Rindi; M N Murphy; G W Stamp; J Hanson; J M Polak; B Hogan
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

5.  Heart tumors specifically induced in young avian embryos by the v-myc oncogene.

Authors:  S Saule; J P Mérigaud; A E Al-Moustafa; F Ferré; P M Rong; P Amouyel; B Quatannens; D Stéhelin; F Dieterlen-Lièvre
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

7.  In vitro mRNA degradation system to study the virion host shutoff function of herpes simplex virus.

Authors:  C R Krikorian; G S Read
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

Authors:  E V Schmidt; P K Pattengale; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 9.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

10.  Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements.

Authors:  D M Ornitz; R W Moreadith; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.